# Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent

> **NCT01939249** · NA · UNKNOWN · sponsor: **Biotronik AG** · enrollment: 585 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Abbott Laboratories Xience
- **DEVICE:** Biotronik Orsiro

## Key facts

- **NCT ID:** NCT01939249
- **Lead sponsor:** Biotronik AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09
- **Primary completion:** 2016-03-23
- **Final completion:** 2020-01
- **Target enrollment:** 585 (ESTIMATED)
- **Last updated:** 2017-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01939249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01939249, "Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01939249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*